Evaluation of the DoD's Mitigation of Foreign Suppliers in the Pharmaceutical Supply Chain (Project No. D2020-DEVOPB-0175.000)

Abstract

We plan to begin our evaluation in September 2020. Our objective is to determine whether the DoD has mitigated the risks of interruptions to the pharmaceutical supply chain, due to the DoD's reliance on foreign suppliers. We will look at the extent of the DoD's reliance on foreign suppliers, supply chain risk management strategies, pharmaceutical reserves, and pharmaceutical quality assurance programs. We may expand the objective and scope during the course of the evaluation if we find program oversight issues that require immediate management attention. We will also consider suggestions from management on additional or revised objectives for this evaluation.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 14, 2020
Accession Number
AD1131010

Entities

Organizations

  • Office of the Inspector General, U.S. Department of Defense

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Acquisition
  • Air Force
  • Business Administration
  • Contingency Operations (Military)
  • Department Of Defense
  • Deployment
  • Electronic Mail
  • Governments
  • Instructions
  • Logistics
  • Military Medicine
  • Military Tactics
  • Procurement
  • Risk
  • Risk Management
  • Supply Chain
  • Supply Chain Management
  • Sustainment
  • Test And Evaluation
  • Unified Combatant Commands

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Defense Acquisition Program Management